India's Revised Capital Market Exposure Rules: Bank Financing Opened for Domestic Acquisitions

India’s revised capital market exposure rules, finalised by the Reserve Bank of India on February 13, 2026, represent the most significant overhaul of bank-market interaction norms in over a decade. The amended Directions explicitly permit commercial banks to extend acquisition financing to eligible domestic corporations, with independent market analyses indicating that compliant structures may access bank funding for up to 75% of acquisition value. Originally scheduled for April 1, 2026, the effective date was deferred by three months to July 1, 2026, following representations from banks and capital market intermediaries. This article explains the new framework’s limits, eligibility criteria, documentation requirements and practical compliance steps for banks, acquirers, private equity sponsors and their legal teams.

Background: Why RBI Changed the Capital Market Exposure Rules

Prior to the 2026 amendments, the RBI’s Master Circular on Exposure Norms governed banks’ capital market exposures through a combination of aggregate ceilings, historically set at 40 per cent of net worth for both fund-based and non-fund-based exposures combined, and a patchwork of individual circulars addressing specific instruments, intermediaries and use-of-proceeds restrictions. The framework, while functional during periods of stable market growth, did not contemplate the scale and complexity of domestic M&A activity that has characterised the Indian economy in recent years.

The RBI first signalled reform in October 2025, when it published draft rules proposing that banks’ total direct exposure to capital markets and acquisition financing be capped at 20% of their Tier-1 capital, with aggregate capital market exposures (direct and indirect) subject to a separate overall ceiling. The draft was followed by a public consultation period, during which banks, industry bodies and capital market intermediaries submitted feedback on operational feasibility, transition timelines and definitional clarity.

The central bank issued the final Amendment Directions on February 13, 2026, after due consideration of the feedback received. The stated policy objectives were threefold: to contain systemic risk arising from concentrated bank-market linkages, to bring India’s exposure norms closer to international prudential standards, and, critically, to create a transparent, rule-based pathway for banks to finance domestic acquisitions, an activity that had previously existed in a regulatory grey zone under the capital market exposure rules India framework.

What the Revised RBI Capital Market Exposure Directions 2026 Say, Practical Summary

The amended Directions redefine the scope, measurement and limits of banks’ capital market exposures. They apply to all commercial banks regulated by the RBI and introduce several key structural changes that practitioners must understand before originating, approving or documenting any capital-market-linked facility.

Key definitions and scope

Banks’ capital market exposures now explicitly encompass both direct exposures (investments in equity shares, convertible instruments, equity-oriented mutual funds, and lending against shares or for acquisition of shares) and indirect exposures (advances to capital market intermediaries, bank guarantees issued in favour of stock exchanges, and funding provided to entities whose primary business involves capital market participation). The RBI’s notification clarifies that the Directions capture both fund-based and non-fund-based facilities.

Comparison: old rules versus the 2026 Directions

Prohibited activities

The Directions introduce explicit prohibitions. Banks may no longer fund capital market intermediaries for proprietary trading activities, and all bank guarantees issued in connection with capital market transactions must be supported by full collateral. These restrictions respond to concerns about indirect leverage building up in the financial system.

Acquisition Financing Under India’s Revised Capital Market Exposure Rules: What Is Permitted and the Precise Limits

Yes, banks can now finance domestic acquisitions under a dedicated regulatory pathway. The Directions allow eligible domestic corporations to secure bank funding for share acquisitions, subject to clearly defined Tier-1–linked limits, loan-to-value (LTV) norms and collateral requirements. According to analysis published by CareEdge, compliant structures may permit bank financing of up to 75% of the acquisition value where appropriate collateral and borrower eligibility criteria are met.

Eligibility criteria for borrowers

• Domestic incorporation. The acquirer must be a company incorporated in India under the Companies Act.
• Creditworthiness. Standard bank credit assessment norms apply; the acquirer must meet the lending bank’s internal credit rating thresholds.
• Permitted purpose. The acquisition must involve the purchase of shares or voting interests in a target company that is also a domestic entity.
• Sponsor support. Where the acquirer is a special purpose vehicle (SPV) or thinly capitalised entity, the Directions expect banks to obtain sponsor guarantees or additional equity commitments as part of the security package.

Exposure limits RBI 2026

The Directions set the direct exposure cap at 20% of a bank’s Tier-1 capital for its total capital market and acquisition financing exposure, a threshold that was first reported during the October 2025 consultation phase. Aggregate capital market exposure (direct plus indirect, fund-based plus non-fund-based) remains subject to a broader ceiling, now also calculated on a Tier-1 basis rather than the former net-worth metric.

Example deal economics

Scenario 1, Strategic buyer: A listed Indian manufacturing company acquires a 100% stake in a domestic target valued at ₹2,000 crore. The acquirer seeks bank financing for 60% of the acquisition value (₹1,200 crore). The lending bank, with Tier-1 capital of ₹15,000 crore, checks that its aggregate direct capital market exposure (including this facility) does not exceed ₹3,000 crore (20% of Tier-1). The facility is structured as a term loan secured by a pledge over the acquired shares, with an LTV not exceeding 75%, plus a corporate guarantee from the acquirer’s parent entity.

Scenario 2, PE sponsor via SPV: A private equity fund routes its acquisition through a domestic SPV. The SPV seeks ₹750 crore of bank debt against a total acquisition cost of ₹1,000 crore. The bank requires the PE sponsor to contribute equity of at least 25% (₹250 crore), obtains a sponsor guarantee capped at the facility amount, takes a first-ranking pledge over target shares, and assigns a higher risk weight to the exposure given the SPV’s limited operating history. The facility amount falls within the bank’s remaining headroom under the 20% Tier-1 direct-exposure cap.

How bank credit committees should model the exposure

Credit committees should treat acquisition financing as a distinct sub-category within their capital market exposure dashboard. Industry observers expect banks to maintain internal sub-limits well below the regulatory ceiling, typically 10–15% of Tier-1, to preserve headroom for market volatility and other capital market facilities. The exposure must be monitored on a mark-to-market basis where shares are pledged, with margin call triggers documented in the facility agreement.

How Banks Must Measure Exposures and Capital Reporting Implications

The shift from net-worth to Tier-1 capital as the measurement denominator has material consequences for exposure calculations. Banks must aggregate all on-balance-sheet and off-balance-sheet items that fall within the Directions’ definitions, including funded loans, investments, guarantees, letters of credit and derivative exposures linked to capital market instruments.

Tier-1 capital treatment

Acquisition financing facilities attract risk weights determined by the nature of the collateral, the borrower’s credit profile and the LTV ratio. Where the sole security is a pledge over listed equity shares, the applicable risk weight is higher than for facilities secured by a diversified collateral pool. Banks must ensure their capital adequacy ratio (CAR) computations reflect these risk-weighted exposures accurately.

Reporting obligations

Banks that fail to establish robust internal monitoring systems before the effective date risk regulatory action, including directions to reduce exposures or restrictions on new capital market lending. The likely practical effect will be that compliance and risk teams need to overhaul their exposure dashboards during the transition window.

Underwriting and Documentation Checklist for Acquisition Financing Under the Capital Market Exposure Rules India

The following checklist consolidates the key underwriting, documentation and covenant requirements that banks and their counsel should address when originating acquisition financing facilities under the revised Directions.

Borrower eligibility and due diligence

• Corporate status verification. Confirm the acquirer is incorporated in India and authorised to undertake the proposed acquisition under its constitutional documents.
• Credit assessment. Apply the bank’s standard internal credit rating methodology; document the rating and any overrides.
• Group exposure check. Verify that the proposed facility, when aggregated with existing exposures to the borrower’s group, does not breach large exposure framework limits or the Directions’ sub-limits.
• Regulatory clearance status. Confirm whether the acquisition requires Competition Commission of India (CCI) approval, sectoral regulator consent or FEMA clearance (for any cross-border elements).

Permitted use and restrictive covenants

• End-use covenant. The facility agreement must restrict drawdown proceeds exclusively to the acquisition of identified shares or voting interests in the specified target.
• Negative pledge. The borrower must covenant not to create any encumbrance over the acquired shares except in favour of the lending bank.
• Sponsor commitment. Where applicable, the sponsor’s equity contribution must be received and verified before the bank’s first disbursement.

Security package

• Share pledge. First-ranking pledge over 100% of the acquired shares, documented with the depository participant and notified to the target company.
• Corporate or sponsor guarantee. Unconditional, irrevocable guarantee from the acquirer’s parent or the PE sponsor, capped at the outstanding facility amount plus accrued interest.
• Margin maintenance. LTV ratio must not exceed 75% at any point; if collateral coverage falls below the agreed threshold, the borrower must top up within a specified cure period (typically 5 business days).

Template clause: end-use restriction

“The Borrower shall apply the proceeds of each Utilisation exclusively towards the acquisition of [number] equity shares of [Target Company] in accordance with the terms of the Share Purchase Agreement dated [date], and shall not divert, re-lend or apply such proceeds for any other purpose whatsoever.”

Template clause: margin call trigger

“If at any time the Loan-to-Value Ratio exceeds [75]%, the Borrower shall, within [5] Business Days of receiving notice from the Lender, either (a) prepay such portion of the Outstanding Amount as is necessary to restore the Loan-to-Value Ratio to [70]% or below, or (b) provide Additional Collateral acceptable to the Lender, failing which the Lender may exercise its rights under the Share Pledge Agreement.”

Template clause: regulatory compliance undertaking

“The Borrower undertakes that it shall at all times comply, and shall procure that each member of the Group complies, with the Reserve Bank of India (Commercial Banks, Capital Market Exposure) Directions, 2026, as amended from time to time, and shall promptly notify the Lender of any actual or anticipated breach thereof.”

Market Impacts and Deal Structuring Under India’s Revised Capital Market Exposure Rules

The 2026 Directions reshape the deal-structuring landscape for both strategic acquirers and financial sponsors. By creating a transparent bank-financing pathway, the rules increase the bankable portion of domestic acquisitions, reducing reliance on offshore debt, promoter equity or high-cost mezzanine instruments. Early indications suggest that the reform is already influencing the capital structure assumptions in live deal processes.

Impact on private equity

PE sponsors structuring acquisitions through domestic SPVs now have a regulatory-compliant route to leverage, provided they meet the eligibility tests and contribute the required minimum equity. Industry observers expect this to increase competition for mid-market acquisition targets, as leverage availability reduces the equity cheque required and improves internal rates of return. However, the covenants, including sponsor guarantees, margin maintenance and restrictive end-use provisions, add compliance cost and operational complexity that sponsors must factor into their fund documentation.

Implications for strategic buyers and sellers

Strategic buyers benefit from the ability to partially debt-finance acquisitions without the regulatory ambiguity that characterised the prior regime. Sellers, in turn, may negotiate shorter closing timelines and more certain funding structures, reducing deal execution risk. The interplay with the Competition Commission of India’s merger review process remains unchanged, but the financing certainty provided by the new rules should reduce the incidence of financing-conditionality clauses in share purchase agreements.

Alternative and complementary instruments

Where the bank-financed portion is limited by the 20% Tier-1 cap or borrower-specific constraints, deal teams should consider complementary structures including seller-financed deferred consideration, escrow arrangements, non-convertible debentures and structured mezzanine facilities. These instruments sit outside the capital market exposure framework and can bridge the gap between bank debt and the acquirer’s equity contribution.

Implementation Timeline, Transition and Early Adoption Options

The RBI issued the final Amendment Directions on February 13, 2026, with an original effective date of April 1, 2026. Following representations from banks and capital market intermediaries requesting additional time for system changes and internal policy updates, the RBI deferred the effective date by three months. The revised deadline is now July 1, 2026. Banks may, however, opt for early adoption, meaning institutions that have completed their internal readiness programmes can implement the Directions before the mandatory date.

The three-month window provides banks additional time to recalibrate internal exposure limits, update credit approval templates, modify reporting dashboards and train front-office teams. For legal teams advising on live transactions, the transition period demands particular vigilance: facilities originated before July 1, 2026, under the old framework remain valid, but any new facility or material amendment executed after the effective date must comply with the revised Directions.

Immediate steps for legal and compliance teams (next 30–90 days): Review and update all standard-form India, Banking & Finance facility documentation to incorporate the new end-use restrictions, margin maintenance covenants and reporting triggers mandated by the Directions. Conduct a gap analysis of existing capital market exposures against the new Tier-1–based limits and prepare board-level briefings on any required de-risking or portfolio adjustments.

Reporting Obligations by Entity Type

Conclusion and Recommended Action Checklist

India’s revised capital market exposure rules mark a decisive regulatory shift, one that opens a transparent, Tier-1–linked pathway for banks to finance domestic acquisitions while imposing tighter controls on intermediary funding and proprietary trading leverage. The following actions should be prioritised by boards, credit committees, legal teams and sponsors:

• Map current exposures. Recalculate all existing capital market exposures on a Tier-1 capital basis and identify headroom under the new 20% direct-exposure cap.
• Update facility templates. Incorporate end-use restrictions, margin maintenance clauses and regulatory compliance undertakings into standard documentation.
• Establish acquisition-financing sub-limits. Set internal sub-limits for acquisition financing below the regulatory ceiling to preserve flexibility.
• Implement daily collateral monitoring. Deploy or upgrade systems for real-time mark-to-market valuation and automated margin call triggers.
• Train front-office and credit teams. Ensure relationship managers and credit officers understand the new eligibility criteria and prohibited activities.
• Engage with the India Banking & Finance lawyer directory for specialist guidance on structuring compliant acquisition financing facilities.
• Monitor RBI clarifications. Track any post-issuance FAQs, guidance notes or amendments published by the RBI before and after the July 1, 2026 effective date.
• Board-level briefing. Present a board note summarising the Directions’ impact on the institution’s capital market strategy and acquisition-financing appetite.

Sources

1. Reserve Bank of India, Capital Market Exposure Directions
2. RBI, Amendment Directions (Deferment)
3. CareEdge / CARE Ratings, Impact Analysis of RBI’s Revised Capital Market Exposure Directions
4. Reuters, India’s RBI Proposes Limits for Banks’ Capital Market Exposure
5. Vinod Kothari Consultants, RBI’s 3-Month Breather for New Rules on Capital Market Exposures
6. King Stubb & Kasiva, RBI Draft Rules Reshape Bank Capital Market Exposure
7. News On AIR, RBI Postpones Implementation of New Rules on Capital Market Exposure